Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections Clinical research trials and Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections. Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections clinical trial. Participants oftentimes recieve the most expert healthcare available for their Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "O" Clinical Trials Conditions > Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections

Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections



Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections

For Condition: Mycoses
Status: Recruiting
Sponsor(s): Schering-Plough ,
Synopsis: This study is designed to evaluate the safety, tolerance and efficacy of Posaconazole (SCH 56592) under an open label, treatment protocol for subjects with invasive fungal infections: A. which are refractory or resistant to standard antifungal therapies; B. for which there are currently no effective therapies; C. with a prior history of serious, severe or life-threatening toxicities while receiving antifungal therapy; D. with pre-existing organ dysfunction which precludes the administration of standard antifungal therapies.
Details: The current clinical trial is designed to provide posaconazole (SCH 56592 to subjects with invasive fungal infections a) which are refractory or resistant to standard antifungal therapies or b) for which there are currently no effective therapies. Subjects with such invasive fungal infections cannot be enrolled in controlled, randomized clinical trials. Secondly, this clinical trial is also designed to provide posaconazole (SCH 56592) to subjects with invasive fungal infections who c) have experienced serious or severe toxicities while receiving standard antifungal therapies or d) have pre-existing organ dysfunction such as renal dysfunction who require standard antifungal therapy which is precluded because of the toxicities associated with such therapy. This clinical trial also serves to allow collection of preliminary data regarding the safety and efficacy of posaconazole (SCH 56592) against a variety of invasive fungal infections which although serious and life-threatening are sufficiently rare so that they cannot be studied in a controlled, randomized clinical trial. This is an open-label, treatment protocol for a multi-center study of posaconazole (SCH 56592) 200mg orally four times daily (QID) while hospitalized followed by posaconazole (SCH 56592) 400mg orally twice daily (BID) on discharge from hospital, in the treatment of invasive fungal infections. Approximately 45 subjects have been enrolled at 25 clinical study centers in the US and worldwide.
Eligibility:
Study Type:
  Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: 13 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Proven or probable invasive fungal infections according to EORTC/MSG criteria. - IFI are documented to be refractory to standard antifungal therapy OR intolerant to standard therapy. - Able to take oral medication or take medication via enteral feeding tube. Exclusion Criteria: - History of serious or severe hypersensitivity or idiosyncratic reactions to azole antifungals. - Concurrent progressive neurological disease (except if due to invasive fungal infection) - Use of medications that are known to interact with azoles and that may lead to life-threatening side effects: terfenadine, cisapride, ebastine at entry or within 24 hours prior to therapy, or astemizole at entry or within 10 days prior to entry.concentration/efficacy of azole antifungals: rifampin, carbamazepine.
Total Enrollment: 

Location and Contact Information:

University of Cincinnati, College of Medicine *Recruiting*
Cincinnati,  Ohio,  45267-0558
United States
Recruiting Joseph  Solomkin 513-558-4427

University of Kentucky Med. Ctr. *Recruiting*
Lexington,  Kentucky,  40536
United States
Recruiting Richard  Greenberg 859-323-6892

Hopital De La Conception *Recruiting*
Marseille,  , 
France
Recruiting Herve  Gallais 04-91-38-35-31

Corporation Para Investigaciones Biologicas CIB *Recruiting*
Medellin,  , 
Colombia
Recruiting Angela  Restrepo 57-4-4415514

Duke University Medical Center *Recruiting*
Durham,  North Carolina,  27710
United States
Recruiting John  Perfect 919-681-6793

Royal University Hospital *Recruiting*
Saskatoon,  ,  S7N 0W8
Canada
Recruiting Stephen  Sanche 306-655-1777

A.P.H. Paris *Recruiting*
Creteil Cedex,  , 
France
Recruiting Catherine  Cordonnier 01.49.81.20.59

Emory Clinic *Recruiting*
Atlanta,  Georgia,  30322
United States
Recruiting Amelia  Langston 404-778-5714

Eastern Maine Medical Center *Recruiting*
Bangor,  Maine,  04401-6612
United States
Recruiting Robert  Pinsky 207-973-5810

Blood and Marrow Transplant Group of Georgia *Recruiting*
Atlanta,  Georgia,  30342
United States
Recruiting Lawrence  Morris 404-255-1930

Dwight David Eisenhower Army Medical Center *Recruiting*
Fort Gordon,  Georgia,  30905-5650
United States
Recruiting Josephine  Skidmore 706-787-6492

William Beaumont Hospital *Recruiting*
Royal Oak,  Michigan,  48073
United States
Recruiting Marcus  Zervos 248-551-6059

Centro de Investigaciones Medicas Asociadas *Recruiting*
Hermosillo,  , 
Mexico
Recruiting Rodrigo  Sanchez-Lopez 62-14-2477

The Children's Hospital *Recruiting*
Denver,  Colorado,  80218
United States
Recruiting Mark  Abzug 303-861-6389

Universitaet Koeln *Recruiting*
Koeln,  ,  50931
Germany
Recruiting Oliver  Cornely 49-221-478-6209

Carilion Infectious Disease *Recruiting*
Roanoke,  Virginia,  24016
United States
Recruiting Jean  Smith 540-981-7715

Hopital De Hautepierre *Recruiting*
Strasbourg Cedex,  , 
France
Recruiting Raoul  Herbrecht 03-88-12-81-48

University of Texas MDAnderson Cancer Center *Recruiting*
Houston,  Texas, 
United States
Recruiting Issam  Raad 713-792-7943

Nemour's Children's Clinic *Recruiting*
Jacksonville,  Florida,  32207
United States
Recruiting Eric  Sandler 904-390-3793

Bringham & Women's Hopsital *Recruiting*
Boston,  Massachusetts, 
United States
Recruiting Lindsey  Baden 617-732-8110

Children's Medical Center *Recruiting*
Dayton,  Ohio,  45404
United States
Recruiting Sherman  Alter 937-641-3329

Hospital Saint Louis *Recruiting*
Paris,  , 
France
Recruiting Eliane  Gluckman 01-42-49-96-39

University of Miami School *Recruiting*
Miami,  Florida,  33136
United States
Recruiting Delia  Rivera 305-243-2756

Kern Medical Center *Recruiting*
Bakersfield,  California, 
United States
Recruiting Royce  Johnson 661-326-2224

University of Nebraska *Recruiting*
Omaha,  Nebraska, 
United States
Recruiting Stefano  Tarantolo 406-329-7005

Hospital Universitario "DR. J.E. Gonzalez" *Recruiting*
Monterrey,  , 
Mexico
Recruiting Adrian  Perez 01-81-8333-83-81

Hospital Nacional Cayetano Heredia *Recruiting*
San Martin de Porres,  , 
Peru
Recruiting Ana  Bustamante 511 319000

Hendrick Medical Center *Recruiting*
Abilene,  Texas, 
United States
Recruiting John  Gullett 915-670-4570

Klinikum der Johannes Gutenberg-Universitaet Mainz *Recruiting*
Mainz,  , 
Germany
Recruiting Andrew  Ullmann 49 6131 17 6564

Loma Linda University *Recruiting*
Loma Linda,  California,  92354
United States
Recruiting Albert  Kheradpour 909-558-8407

Klinikum der Ludewig Maximillians, Univ. Muenchen *Recruiting*
Muenchen,  , 
Germany
Recruiting Xaver  Schiel 49-89-70950

Cleveland Clinic Foundation *Recruiting*
Cleveland,  Ohio,  44195-5032
United States
Recruiting Steven  LaRosa 216-445-2420

Beth Israel Deaconess Medical Center *Recruiting*
Boston,  Massachusetts,  02215
United States
Recruiting Michael  Wong 617-632-0760

The Children's Mercy Hospital Center *Recruiting*
Kansas City,  Missouri, 
United States
Recruiting Andrew  Gilman 816-234-3265

The Univerity of Iowa *Recruiting*
Iowa City,  Iowa,  52242
United States
Recruiting Rachel  Miller 319-356-3674

University of Minnesota *Recruiting*
Minneapolis,  Minnesota,  55455
United States
Recruiting Jo-Ann  Burik 612-273-6212

Instituto Nacional Do Cancer *Recruiting*
Rio de Janiero,  , 
Brazil
Recruiting Marcelo  Schirmer 5521-22174214

Rush Presbyterian St. Luke's Medical Center *Recruiting*
Chicago,  Illinois,  60612
United States
Recruiting Laurie  Proia 312-942-5865

Emory University *Recruiting*
Atlanta,  Georgia, 
United States
Recruiting Amelia  Langston 404-778-4189

Hospital De Infectologia, Centro Medico Nacional "La Raza" IMASS *Recruiting*
Mexico, D.F.,  , 
Mexico
Recruiting Veronica  Flores 525-583-22-11

Naval Medical Center San Diego *Recruiting*
San Diego,  California, 
United States
Recruiting Braden  Hale 619-532-7475

The Children's Hopsital *Recruiting*
Denver,  Colorado, 
United States
Recruiting Mark  Abzug 303-861-6389

Cleveland Clinic Foundation Infectious Disease *Recruiting*
Cleveland,  Ohio, 
United States
Recruiting Steven  Larosa 216-444-5519

Harbor-UCLA Research and Education Institute *Recruiting*
Torrance,  California,  90502
United States
Recruiting John  Edwards 310-333-3813

New England Medical Center *Recruiting*
Boston,  Massachusetts,  02111
United States
Recruiting Susan  Hadley 617-636-3099

University of Texas Health Sciences Center *Recruiting*
San Antonio,  Texas,  78229
United States
Recruiting Richard  Graybill 210-617-5111

Hospital Das Clinicas Da FMUSP *Recruiting*
Sao Paulo - SP,  , 
Brazil
Recruiting Maria  Yasuda 5511-3061-5544

Instituto Nacional Do Cancer Corporaction para Investigaciones *Recruiting*
Rio de Janeiro,  , 
Brazil
Recruiting Marcelo  Schirmer 5521-221-74214

Methodist Hospital German *Recruiting*
Germantown,  Tennessee,  38138
United States
Recruiting Stephen  Threlkeld 901-55-5200

Institut Jules Bordet *Recruiting*
Brussels,  , 
Belgium
Recruiting Mickael  Aoun 32 2 541 37 09

Basel Kantonsspital *Recruiting*
Basel,  , 
Switzerland
Recruiting Basel  Kantonsspital

Loyola University Medical Center *Recruiting*
Maywood,  Illinois,  60153
United States
Recruiting Kathleen  Mullane 708-216-8777

C.H.U. de Strasbourg, Hopital de Hautepierre *Recruiting*
Strasbourg,  , 
France
Recruiting Raoul  Herbrecht 03-88-12-8148

Hospital Francisco J Muniz *Recruiting*
Buenos Aires,  , 
Argentina
Recruiting Ricardo  Negroni 54 11 4304 4655

National Institute of Health *Recruiting*
Bethesda,  Maryland,  20892
United States
Recruiting Steven  Holland 301-496-1211

University of Florida - College of Medicine *Recruiting*
Gainesville,  Florida,  32610
United States
Recruiting Minh-Hong  Nguyen 352-379-4027

Texas Tech University *Recruiting*
Odessa,  Texas,  79763
United States
Recruiting Karlene  Reid 915-335-5250

Hopital Maisonneuve-Rosemont *Not yet recruiting*
Montreal,  , 
Canada
Not yet recruiting Michael  Laverdiere 514 252 3817

Childrens Hospital Los Angeles *Recruiting*
Los Angeles,  California,  90027
United States
Recruiting Jill  Hoffman 323-669-2509

Memorial Sloan Kettering Infectious Disease *Recruiting*
New York City,  New York,  10021
United States
Recruiting Josephine  Seo 212-639-7810

UCSD Medical Center *Recruiting*
San Diego,  California,  92103
United States
Recruiting Antonino  Catanzaro 619-543-6222

The Queen's Physicians *Recruiting*
Honolulu,  Hawaii,  96813
United States
Recruiting William  Lau 808-532-2955

Brigham & Women's Hospital *Recruiting*
Boston,  Massachusetts,  02115
United States
Recruiting Lindsey  Baden 619-532-6131

St. Jude Children's Research Hospital *Recruiting*
Memphis,  Tennessee,  38105
United States
Recruiting Katherine  Knapp 901-495-3252

University Of Cape Town, Dept Of Hematology *Recruiting*
Cape Town,  , 
South Africa
Recruiting Nicolas  Novitzky 27-21-404-3073

Royal University Hospital *Not yet recruiting*
Saskatoon,  , 
Canada
Not yet recruiting Stephen  Sanche 306-655-1777


Additional Information:
Study ID Numbers:
  P02095;  yes
Study Start Date: September 2001
Record last reviewed: May 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00034632

Other Mycoses Studies:
1. An Open Label, Non-comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

2. Voriconazole to Prevent Systemic Fungal Infections in Children

3. Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

4. Voriconazole to Treat Fungal Infections

5. Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)

Related Studies:

Other Mycoses Clinical Trials
Other Florida Clinical Trials
Other Gainesville Clinical Trials

Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections

Modify your Search

  Other Mycoses Clinical Trials
  Other Florida Clinical Trials
  Other Gainesville Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103